Biden-Harris Push for Medicare, Medicaid Coverage of Anti-Obesity Drugs

• The Biden-Harris Administration proposes expanding Medicare and Medicaid to cover anti-obesity medications like Ozempic and Wegovy.
• This move aims to make these costly treatments more accessible, potentially reducing out-of-pocket expenses by up to 95% for millions.
• HHS Secretary Xavier Becerra emphasizes the importance of addressing obesity to improve public health and reduce economic burdens.

Source: Benzinga, Raw Story